Investigational Site Number 840002

New York, New York 10021

0 studies enrolling now · 2 studies all time

What they study most

Astrocytoma, Grade IV, Glioblastoma, Neoplasm Malignant

Studies at this site

• Phase 1 Safety Testing of SAR405838 — Completed
• Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection — Completed